Treatment trajectories of patients with borderline personality disorder prescribed pharmacotherapy: real-world insights from a retrospective observational study.
Saved in:
| Title: | Treatment trajectories of patients with borderline personality disorder prescribed pharmacotherapy: real-world insights from a retrospective observational study. |
|---|---|
| Authors: | White C; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. carissa.dukes@boehringer-ingelheim.com., St Rose S; Boehringer Ingelheim International GmbH, Binger Strasse 173, 55216, Ingelheim am Rhein, Germany., Dwyer JB; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Palmer EOC; Holmusk Technologies, Inc., London, UK., Yeow J; Holmusk Technologies, Inc., Singapore, Singapore., Griffiths K; Holmusk Technologies, Inc., London, UK., Chee B; Holmusk Technologies, Inc., Singapore, Singapore., Oyesanya M; Holmusk Technologies, Inc., London, UK., Patel R; Department of Psychiatry, University of Cambridge, Cambridge, UK. |
| Source: | BMC psychiatry [BMC Psychiatry] 2026 Mar 20; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 20. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1471-244X |
|---|---|
| DOI: | 10.1186/s12888-026-07974-6 |
